February 2023
1. HUBER S, Haferlach T, Meggendorfer M, Hutter S, et al
   Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
   Leukemia. 2023;37:500-502.
   

   >> Share

   
   October 2022
2. PAGLIUCA S, Gurnari C, Hercus C, Hergalant S, et al
   Molecular landscape of immune pressure and escape in aplastic anemia.
   Leukemia. 2022 Oct 17. pii: 10.1038/s41375-022-01723.
   

   >> Share

   
   September 2022
3. MESA R, Harrison C, Oh ST, Gerds AT, et al
   Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
   Leukemia. 2022;36:2261-2268.
   

   >> Share

   
   August 2022
4. KELKKA T, Tyster M, Lundgren S, Feng X, et al
   Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.
   Leukemia. 2022 Aug 5. pii: 10.1038/s41375-022-01654.
   

   >> Share

   
   July 2022
5. GROARKE EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, et al
   Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
   Leukemia. 2022 Jul 27. pii: 10.1038/s41375-022-01636.
   

   >> Share

   
   May 2022
6. HUANG Y, Chen M, Yang C, Ruan J, et al
   Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
   Leukemia. 2022;36:1351-1360.
   

   >> Share

   
   
7. KOMROKJI RS, Platzbecker U, Fenaux P, Zeidan AM, et al
   Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
   Leukemia. 2022;36:1432-1435.
   

   >> Share

   
   April 2022
8. TSUJI N, Hosokawa K, Urushihara R, Tanabe M, et al
   Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
   Leukemia. 2022 Apr 26. pii: 10.1038/s41375-022-01549.
   

   >> Share

   
   
9. SWOBODA DM, Kanagal-Shamanna R, Brunner AM, Cluzeau T, et al
   Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
   Leukemia. 2022;36:1189-1192.
   

   >> Share

   
   January 2022
10. LIN Q, Lian J, Wu J, Meng P, et al
    Erythropoietin receptor contributes to thrombopoietin receptor (Mpl)-independent thrombocytopoiesis in zebrafish.
    Leukemia. 2022 Jan 18. pii: 10.1038/s41375-021-01495.
    

    >> Share

    
    October 2021
11. ZHOU C, Kuang M, Liu Z, Jia X, et al
    Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.
    Leukemia. 2021 Oct 11. pii: 10.1038/s41375-021-01445.
    

    >> Share

    
    September 2021
12. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 Sep 2. pii: 10.1038/s41375-021-01396.
    

    >> Share

    
    August 2021
13. FEURSTEIN S, Churpek JE, Walsh T, Keel S, et al
    Germline variants drive myelodysplastic syndrome in young adults.
    Leukemia. 2021;35:2439-2444.
    

    >> Share

    
    
14. GURNARI C, Pagliuca S, Patel BJ, Awada H, et al
    Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
    Leukemia. 2021;35:2431-2434.
    

    >> Share

    
    June 2021
15. GURNARI C, Durrani J, Pagliuca S, Kishtagari A, et al
    Novel invariant features of Good syndrome.
    Leukemia. 2021;35:1792-1796.
    

    >> Share

    
    May 2021
16. CERVANTES F, Ross DM, Radinoff A, Palandri F, et al
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study.
    Leukemia. 2021 May 20. pii: 10.1038/s41375-021-01261.
    

    >> Share

    
    April 2021
17. YOROIDAKA T, Hosokawa K, Imi T, Mizumaki H, et al
    Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
    Leukemia. 2021 Apr 6. pii: 10.1038/s41375-021-01202.
    

    >> Share

    
    
18. ZHANG L, Chen JY, Kerr C, Cobb BA, et al
    Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Leukemia. 2021;35:1176-1187.
    

    >> Share

    
    March 2021
19. LUNDGREN S, Keranen MAI, Kankainen M, Huuhtanen J, et al
    Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia.
    Leukemia. 2021 Mar 30. pii: 10.1038/s41375-021-01231.
    

    >> Share

    
    
20. SEYFRIED AN, McCabe A, Smith JNP, Calvi LM, et al
    CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia.
    Leukemia. 2021 Mar 20. pii: 10.1038/s41375-021-01219.
    

    >> Share

    
    
21. FATTIZZO B, Ireland R, Dunlop A, Yallop D, et al
    Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
    Leukemia. 2021 Mar 4. pii: 10.1038/s41375-021-01190.
    

    >> Share

    
    November 2020
22. SPORTOLETTI P, Sorcini D, Guzman AG, Reyes JM, et al
    Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.
    Leukemia. 2020 Nov 6. pii: 10.1038/s41375-020-01075.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share